157 related articles for article (PubMed ID: 15329096)
1. Adjuvant topical treatment of upper urinary tract urothelial tumours.
O'Donoghue JP; Crew JP
BJU Int; 2004 Sep; 94(4):483-5. PubMed ID: 15329096
[No Abstract] [Full Text] [Related]
2. Intravesical bacillus Calmette-Guérin combined with electromotive mitomycin for high-risk superficial bladder cancer.
Bochner BH
Nat Clin Pract Oncol; 2006 Sep; 3(9):474-5. PubMed ID: 16955082
[No Abstract] [Full Text] [Related]
3. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.
Hellenthal NJ; Shariat SF; Margulis V; Karakiewicz PI; Roscigno M; Bolenz C; Remzi M; Weizer A; Zigeuner R; Bensalah K; Ng CK; Raman JD; Kikuchi E; Montorsi F; Oya M; Wood CG; Fernandez M; Evans CP; Koppie TM
J Urol; 2009 Sep; 182(3):900-6. PubMed ID: 19616245
[TBL] [Abstract][Full Text] [Related]
4. Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes.
Metcalfe M; Wagenheim G; Xiao L; Papadopoulos J; Navai N; Davis JW; Karam JA; Kamat AM; Wood CG; Dinney CP; Matin SF
J Endourol; 2017 Sep; 31(9):946-953. PubMed ID: 28731777
[TBL] [Abstract][Full Text] [Related]
5. Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes.
Audenet F; Traxer O; Bensalah K; Rouprêt M
World J Urol; 2013 Feb; 31(1):45-52. PubMed ID: 23007718
[TBL] [Abstract][Full Text] [Related]
6. Effects of intravesical chemotherapy and immunotherapy on semen analysis.
Raviv G; Pinthus JH; Shefi S; Mor Y; Kaufman-Francis K; Levron J; Weissenberg R; Ramon J; Madgar I
Urology; 2005 Apr; 65(4):765-7. PubMed ID: 15833524
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract.
Kwak C; Lee SE; Jeong IG; Ku JH
Urology; 2006 Jul; 68(1):53-7. PubMed ID: 16806415
[TBL] [Abstract][Full Text] [Related]
8. A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guérin therapy?
Rastinehad AR; Ost MC; Vanderbrink BA; Greenberg KL; El-Hakim A; Marcovich R; Badlani GH; Smith AD
Urology; 2009 Jan; 73(1):27-31. PubMed ID: 18929398
[TBL] [Abstract][Full Text] [Related]
9. Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury.
Chen F; Zhang G; Cao Y; Payne R; See WA
J Urol; 2007 Nov; 178(5):2166-70. PubMed ID: 17870116
[TBL] [Abstract][Full Text] [Related]
10. [New concepts in the management of upper tract urinary carcinoma in 2010].
Pignot G; Rouprêt M; Lechevallier E; Rolland F
Prog Urol; 2011 Mar; 21 Suppl 2():S43-5. PubMed ID: 21397827
[TBL] [Abstract][Full Text] [Related]
11. [A comparative study of BCG and mitomycin C in superficial carcinomas of the bladder].
Iavarone C; Minocchi L; Arecchi S; Nicolucci D; Porcelli C; D'orazi V; Greco L; Stio F; Martino G; Messinetti S
G Chir; 1996 May; 17(5):289-91. PubMed ID: 8755233
[No Abstract] [Full Text] [Related]
12. Salvage topical therapy for upper tract urothelial carcinoma.
Balasubramanian A; Metcalfe MJ; Wagenheim G; Xiao L; Papadopoulos J; Navai N; Davis JW; Karam JA; Kamat AM; Wood CG; Dinney CP; Matin SF
World J Urol; 2018 Dec; 36(12):2027-2034. PubMed ID: 29804202
[TBL] [Abstract][Full Text] [Related]
13. Intravesical chemotherapy use after radical nephroureterectomy: A national survey of urologic oncologists.
Lu DD; Boorjian SA; Raman JD
Urol Oncol; 2017 Mar; 35(3):113.e1-113.e7. PubMed ID: 27884539
[TBL] [Abstract][Full Text] [Related]
14. Bacillus Calmette-Guérin versus mitomycin C for the treatment of intermediate-risk non-muscle-invasive bladder cancer: the debate continues.
Sylvester RJ
Eur Urol; 2009 Aug; 56(2):266-8; discussion 268-9. PubMed ID: 19427110
[No Abstract] [Full Text] [Related]
15. Novel treatment of upper tract urothelial carcinoma in situ with docetaxel in BCG refractory patients.
Katims AB; Tam AW; Rosen DC; Zampini AM; Atallah W; Mehrazin R; Gupta M
Urol Oncol; 2021 Apr; 39(4):234.e9-234.e13. PubMed ID: 32958446
[TBL] [Abstract][Full Text] [Related]
16. Treatment options for upper tract transitional-cell carcinoma.
Seaman EK; Slawin KM; Benson MC
Urol Clin North Am; 1993 May; 20(2):349-54. PubMed ID: 8493753
[TBL] [Abstract][Full Text] [Related]
17. Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors.
Eastham JA; Huffman JL
J Urol; 1993 Aug; 150(2 Pt 1):324-5. PubMed ID: 8326553
[TBL] [Abstract][Full Text] [Related]
18. Ureteric angioplasty balloon placement to increase localised dosage of BCG for renal pelvis TCC.
Forde JC; O'Connor KM; Fanning DM; Guiney MJ; Grainger R
Ir Med J; 2012 Mar; 105(3):87-8. PubMed ID: 22558818
[TBL] [Abstract][Full Text] [Related]
19. Treatment of urothelial carcinoma of the upper urinary tract following prostatocystectomy with mitomycin C instillation in the ileal loop.
van Helsdingen PJ; Rikken CH
J Urol; 1986 Aug; 136(2):461-3. PubMed ID: 3090277
[TBL] [Abstract][Full Text] [Related]
20. Intracavitary therapy of noninvasive transitional cell carcinomas of the upper urinary tract. A review of the literature.
Bassi P; Iafrate M; Longo F; Iannello A; Mostaccio G; Ingrassia A; Repele M; Tavolini IM
Urol Int; 2001; 67(3):189-94. PubMed ID: 11598443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
